Home > Insider Trading > Filing (0001209191-20-047455)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1515673	Ultragenyx Pharmaceutical Inc.	RARE	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1377202	Shalini Sharp	C/O Ultragenyx Pharmaceutical Inc. 60 Leveroni Court Novato CA 94949	Cfo & Executive Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-08-17	461	$88.24	100,747	No	4	S	Direct
Common Stock	Disposition	2020-08-17	2,560	$88.54	98,187	No	4	S	Direct
Common Stock	Acquisiton	2020-08-17	500	$70.57	98,687	No	4	M	Direct
Common Stock	Disposition	2020-08-17	500	$88.38	98,187	No	4	S	Direct
Common Stock	Acquisiton	2020-08-17	7,188	$67.55	105,375	No	4	M	Direct
Common Stock	Disposition	2020-08-17	7,188	$88.38	98,187	No	4	S	Direct
Common Stock	Acquisiton	2020-08-17	3,669	$48.43	101,856	No	4	M	Direct
Common Stock	Disposition	2020-08-17	3,669	$88.38	98,187	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-08-17	500	$0.00	500	$70.57
Common Stock	Stock Option (Right to Buy)	Disposition	2020-08-17	7,188	$0.00	7,188	$67.55
Common Stock	Stock Option (Right to Buy)	Disposition	2020-08-17	3,669	$0.00	3,669	$48.43

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2026-06-01	No	4	M	Direct
15,812	2029-03-01	No	4	M	Direct
15,312	2028-03-01	No	4	M	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.45 to $88.55 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.17 to $88.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
1/4th of the option vested one year from June 1, 2016 and then 1/48th of the option vested monthly thereafter.
1/4th of the option vested one year from March 1, 2019 and then 1/48th of the option vested monthly thereafter.
1/4th of the option vested one year from March 1, 2018 and then 1/48th of the option vested monthly thereafter.